CHIARADONNA, FERDINANDO
 Distribuzione geografica
Continente #
NA - Nord America 7.018
EU - Europa 4.982
AS - Asia 3.576
SA - Sud America 541
AF - Africa 64
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 5
Totale 16.196
Nazione #
US - Stati Uniti d'America 6.809
IT - Italia 1.402
SG - Singapore 1.382
DE - Germania 1.027
CN - Cina 989
RU - Federazione Russa 548
BR - Brasile 442
HK - Hong Kong 441
PL - Polonia 339
SE - Svezia 335
VN - Vietnam 296
IE - Irlanda 282
GB - Regno Unito 233
FR - Francia 164
UA - Ucraina 160
CA - Canada 156
FI - Finlandia 136
IN - India 103
NL - Olanda 86
AT - Austria 72
ID - Indonesia 69
DK - Danimarca 63
KR - Corea 63
TR - Turchia 63
AR - Argentina 45
MX - Messico 42
JP - Giappone 37
ZA - Sudafrica 32
BE - Belgio 29
BD - Bangladesh 26
CH - Svizzera 25
ES - Italia 25
IR - Iran 20
IQ - Iraq 16
CZ - Repubblica Ceca 15
EC - Ecuador 15
PY - Paraguay 9
TW - Taiwan 9
CL - Cile 8
CO - Colombia 8
PK - Pakistan 8
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
LT - Lituania 7
LU - Lussemburgo 7
TN - Tunisia 7
VE - Venezuela 7
AU - Australia 6
EG - Egitto 6
GR - Grecia 5
MA - Marocco 5
PA - Panama 5
AL - Albania 4
KG - Kirghizistan 4
MY - Malesia 4
NZ - Nuova Zelanda 4
PE - Perù 4
PH - Filippine 4
SA - Arabia Saudita 4
SK - Slovacchia (Repubblica Slovacca) 4
AZ - Azerbaigian 3
DZ - Algeria 3
EU - Europa 3
HU - Ungheria 3
KE - Kenya 3
NO - Norvegia 3
NP - Nepal 3
RO - Romania 3
SN - Senegal 3
UY - Uruguay 3
BH - Bahrain 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
IL - Israele 2
JM - Giamaica 2
JO - Giordania 2
PS - Palestinian Territory 2
PT - Portogallo 2
A1 - Anonimo 1
BG - Bulgaria 1
BS - Bahamas 1
DM - Dominica 1
GE - Georgia 1
HR - Croazia 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MN - Mongolia 1
QA - Qatar 1
SC - Seychelles 1
SY - Repubblica araba siriana 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 16.196
Città #
Ann Arbor 1.229
Singapore 820
Frankfurt am Main 684
Ashburn 662
Woodbridge 501
Milan 441
Hong Kong 433
Fairfield 404
Wilmington 342
Chandler 336
Houston 291
Kraków 280
Dublin 274
Dallas 235
Beijing 186
New York 176
Jacksonville 168
Dearborn 167
Seattle 162
Hefei 159
Santa Clara 147
Cambridge 146
Los Angeles 136
Munich 132
Princeton 84
The Dalles 82
Ho Chi Minh City 78
Buffalo 68
Helsinki 66
Nanjing 62
Jakarta 61
Seoul 59
Shanghai 58
Hanoi 52
Moscow 52
Dong Ket 49
Vienna 49
São Paulo 48
Lawrence 42
Warsaw 42
Guangzhou 40
Montréal 38
Chicago 37
Rome 37
San Diego 36
Boardman 35
Council Bluffs 34
Toronto 34
Altamura 32
Cento 32
Brussels 28
Denver 28
Lachine 28
Tokyo 26
Atlanta 25
Nanchang 25
Nuremberg 25
Johannesburg 24
Montreal 24
Chennai 23
Poplar 22
Orem 21
Tianjin 21
London 20
Torino 20
Bologna 19
Zhengzhou 19
Andover 18
Ankara 18
Brooklyn 18
Falls Church 18
Naples 18
Salt Lake City 17
Turin 17
Kent 16
Rio de Janeiro 15
Stockholm 15
Amsterdam 14
Brusuglio 14
Hyderabad 14
Kunming 14
Hebei 13
Huizen 13
Paris 13
Phoenix 13
Sacramento 13
Manchester 12
Querétaro 12
Shenyang 12
Turku 12
Bergamo 11
Lappeenranta 11
Mumbai 11
Seveso 11
Tampa 11
Verona 11
Brescia 10
Columbus 10
Fremont 10
Jiaxing 10
Totale 10.661
Nome #
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 633
Inhibition of the Hexosamine Biosynthetic Pathway by targeting PGM3 causes breast cancer growth arrest and apoptosis 623
ALDOC- and ENO2- driven glucose metabolism sustains 3D tumor spheroids growth regardless of nutrient environmental conditions: a multi-omics analysis 614
Fuzzy modeling and global optimization to predict novel therapeutic targets in cancer cells 479
Design, Synthesis, and Preliminary Biological Evaluation of GlcNAc-6P Analogues for the Modulation of Phosphoacetylglucosamine Mutase 1 (AGM1/PGM3) 457
The Nutrient-Sensing Hexosamine Biosynthetic Pathway as the Hub of Cancer Metabolic Rewiring. 416
Protein Kinase A Activation Promotes Cancer Cell Resistance to Glucose Starvation and Anoikis 409
Hexosamine pathway inhibition overcomes pancreatic cancer resistance to gemcitabine through unfolded protein response and EGFR-Akt pathway modulation 384
Central metabolism of functionally heterogeneous mesenchymal stromal cells 361
From cancer metabolism to new biomarkers and drug targets 355
Analysis of mitochondrial metabolism in situ: Combining stable isotope labeling with selective permeabilization 350
Mitochondria in Focus: Targeting the Cell-Death Mechanism 334
Transcriptional profiling of immortalized and K-ras-transformed mouse fibroblasts upon PKA stimulation by forskolin in low glucose availability 325
RAS and PKA pathways in cancer: new insight from transcriptional analysis 318
Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth 309
Ras-dependent carbon metabolism and transformation in mouse fibroblasts 296
Expression of transforming K-Ras oncogene affects mitochondrial function and morphology in mouse fibroblasts 291
Cancer cell growth and survival as a system-level property sustained by enhanced glycolysis and mitochondrial metabolic remodeling 291
The Role of Mitochondria in the Chemoresistance of Pancreatic Cancer Cells 283
Suppression of the HBP Function Increases Pancreatic Cancer Cell Sensitivity to a Pan-RAS Inhibitor 277
Metabolic reprogramming and dysregulated metabolism: Cause, consequence and/or enabler of environmental carcinogenesis? 269
New Insights into the Connection between Histone Deacetylases, Cell Metabolism, and Cancer 268
Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: The challenge ahead 268
Energy metabolism characterization of a novel cancer stem cell-like line 3AB-OS 266
Glucose starvation induces cell death in K-ras-transformed cells by interfering with the hexosamine biosynthesis pathway and activating the unfolded protein response 261
Data recovery and integration from public databases uncovers transformation-specific transcriptional downregulation of cAMP-PKA pathway-encoding genes 257
Integrative transcriptional analysis between human and mouse cancer cells provides a common set of transformation associated genes 255
Glutamine deprivation induces abortive S-phase rescued by deoxyribonucleotides in K-ras transformed fibroblasts 248
Oncogenic K-ras expression is associated with derangement of the cAMP/PKA pathway and forskolin-reversible alterations of mitochondrial dynamics and respiration 245
Acquired glucose sensitivity of k-ras transformed fibroblasts 243
Systems biology and the molecular circuits of cancer 239
Genetic and Molecular Characterization of The Human Osteosarcoma 3AB-OS Cancer Stem Cell Line: A Possible Model For Studying Osteosarcoma Origin and Stemness 239
Cancer Metabolism as a New Real Target in Tumor Therapy 237
Targeting the Unfolded Protein Response for Breast and Pancreatic Cancer Therapy 235
Mitochondrial Complex I inhibitors and forced oxidative phosphorylation synergize in inducing cancer cell death 229
The Association between Vitamin D and Gut Microbiota: A Systematic Review of Human Studies 229
Towards a systems biology approach to mammalian cell cycle: modeling the entrance into S phase of quiescent fibroblasts after serum stimulation 224
Redox-Mediated Suberoylanilide Hydroxamic Acid Sensitivity in Breast Cancer 222
PKA stimulation protects K-ras transformed cells from apoptosis induced by glucose depletion reactivating mitochondrial function 218
Mitochondrial Complex I decrease is responsible for bioenergetic dysfunction in K-ras transformed cells 213
PGM3 inhibition Shows cooperative Effects With Erastin inducing Pancreatic cancer cell death via activation of the Unfolded Protein Response 211
PGC1α/β Expression Predicts Therapeutic Response to Oxidative Phosphorylation Inhibition in Ovarian Cancer 210
Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth 209
Vitamin D supplementation and cancer mortality: Narrative review of observational studies and clinical trials 201
Chiral trimethyl lock based on vicinal disubstituent effect: prolonged release of Camptothecin into cancer cells 196
Vitamin D and SARS-CoV2 infection, severity and mortality: A systematic review and meta-analysis 182
Glucose shortage dependent apoptosis in transformed cells upon activation of UPR-autophagy pathway 180
PGM3 inhibition shows cooperative effects with Erastin inducing pancreatic cancer cell death via activation of the Unfolded Protein Response 173
Multi-pathway blood biomarkers to target and monitor multidimensional prevention of cognitive and functional decline (nested in the IN-TeMPO study framed within the world-wide FINGERS network) 171
ALDOC- and ENO2- driven glucose metabolism sustains 3D tumor spheroids growth regardless of nutrient environmental conditions: a multi-omics analysis 150
Moving beyond the Tip of the Iceberg: DJ-1 Implications in Cancer Metabolism 146
Targeting the Unfolded Protein Response for Breast and Pancreatic Cancer Therapy 145
Itaconate controls its own synthesis via feedback-inhibition of reverse TCA cycle activity at IDH2 143
PGM3 insufficiency: a glycosylation disorder causing a notable T cell defect 142
Targeting the Unfolded Protein Response for Breast and Pancreatic Cancer Therapy 132
VITAMIN D SUPPLEMENTATION MAY IMPROVE COVID-19 PROGNOSIS? EVIDENCE FROM A SYSTEMATIC REVIEW AND META-ANALYSIS 130
PO-259 Inhibition of the hexosamine biosynthetic pathway by targeting PGM3 causes breast cancer growth arrest and apoptosis 126
Hexosamine Pathway inhibition: one molecule able to induce a Brcaness phenotype as promising cancer therapy 114
Comparative transcriptional analysis between a K-ras cell model of transformation and the NCI60 human cancer cells collection 101
High throughput metabolomics analysis in normal and K-Ras transformed murine fibroblasts 88
PGM3 Inhibition as a Novel Strategy to Induce BRCAness in HR-Proficient Pancreatic Cancer Cells 85
Inhibition of the Hexosamine Biosynthetic Pathway Enhances Enzalutamide Response in Prostate Cancer Cells 83
Hexosamine Biosynthetic Pathway inhibition sensitizes pancreatic cancer cells to DNA damage 83
Targeting the Hexosamine Biosynthetic Pathway with a novel PGM3 inhibitor, FR054, to suppress tumour growth and enhance chemotherapy sensitivity in cancer 81
PGM3 Inhibition as a Novel Strategy to Induce BRCAness in HR-Proficient Pancreatic Cancer Cells 76
Hexosamine Biosynthetic Pathway inhibition cooperates with gemcitabine inducing in vitro and in vivo pancreatic cancer regression by enhancing DNA damage 73
Targeting Hexosamine Biosynthetic Pathway to Overcome Resistance in Pancreatic Cancer Treatment 60
Exploiting DNA damage response protein O-glycosylation to enhance chemotherapy in pancreatic cancer. 50
PGM3 inhibition shows cooperative effects with erastin inducing pancreatic cancer cell death via activation of the unfolded protein response 47
Targeting Hexosamine Biosynthetic Pathway to Overcome Resistance in Pancreatic Cancer Treatment 47
PGM3 insufficiency: a glycosylation disorder causing a notable T cell defect 47
Exploiting DNA damage protein O-glycosylation to enhance chemotherapy in pancreatic cancer 47
PGM3 inhibition shows cooperative effects with erastin inducing pancreatic cancer cell death via activation of the unfolded protein response 45
Hexosamine biosynthetic pathway inhibition cooperates with gemcitabine inducing in vitro and in vivo pancreatic cancer regression by enhancing DNA damage 36
Inhibition of HBP by targeting PGM3 enzyme as new anticancer therapy 34
Histone glycation: a novel epigenetic target in breast cancer 24
null 3
Totale 16.741
Categoria #
all - tutte 48.818
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.818


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021905 0 0 0 0 0 94 95 112 122 154 125 203
2021/20221.055 107 94 124 110 87 91 59 43 53 43 101 143
2022/20231.440 157 403 162 156 104 183 11 78 102 6 59 19
2023/2024975 24 38 27 79 100 217 203 44 65 34 23 121
2024/20253.104 176 254 296 141 214 140 255 156 265 447 307 453
2025/20264.869 737 467 770 940 1.139 816 0 0 0 0 0 0
Totale 16.741